22 filings
SC 13G/A
VINC
Vincerx Pharma Inc
13 Feb 24
Vincerx Pharma / Affinity Asset Advisors ownership change
4:55pm
13F-HR
Affinity Asset Advisors, LLC
13 Feb 24
Quarterly holdings report by institutional manager
4:52pm
SC 13G/A
SYRE
Spyre Therapeutics Inc.
13 Feb 24
Spyre Therapeutics / Affinity Asset Advisors ownership change
4:48pm
SC 13G/A
Affinity Asset Advisors, LLC
13 Feb 24
Context Therapeutics / Affinity Asset Advisors ownership change
4:45pm
13F-HR
Affinity Asset Advisors, LLC
14 Nov 23
Quarterly holdings report by institutional manager
12:00am
13F-HR/A
d9lyf0sc5psm
21 Aug 23
Quarterly holdings report by institutional manager (amended)
4:07pm
13F-HR
nv9rbpkis2xxr310
14 Aug 23
Quarterly holdings report by institutional manager
4:14pm
SC 13G
z7svq0q
3 Jul 23
Aeglea BioTherapeutics / Affinity Asset Advisors ownership change
4:20pm
13F-HR
w92t8zupihrr3dbmkig
15 May 23
Quarterly holdings report by institutional manager
4:08pm
SC 13G/A
4ct7m5ioqzj
13 Feb 23
Vincerx Pharma / Affinity Asset Advisors ownership change
4:11pm
13F-HR
67fvctlzhd3ryim8tf
13 Feb 23
Quarterly holdings report by institutional manager
4:04pm
13F-HR
g7mdoo yhnzdrcfj
14 Nov 22
Quarterly holdings report by institutional manager
12:00am
13F-HR
uw1vnahfi7p2xhp
12 Aug 22
Quarterly holdings report by institutional manager
4:22pm
13F-HR
cp6mnwp
13 May 22
Quarterly holdings report by institutional manager
4:33pm
SC 13G
ptpwfssl
9 May 22
Context Therapeutics / Affinity Asset Advisors ownership change
5:11pm
SC 13G/A
mm4gug7
11 Feb 22
Vincerx Pharma / Affinity Asset Advisors ownership change
4:13pm
13F-HR
mgftk2s3n1 84h
11 Feb 22
Quarterly holdings report by institutional manager
4:11pm
SC 13G
fod8875x2ybmc2
22 Nov 21
Vincerx Pharma / Affinity Asset Advisors ownership change
2:50pm
13F-HR
gq1nvjyd bq5y
12 Nov 21
Quarterly holdings report by institutional manager
4:35pm
13F-HR
1qmsg lnopx9lu
13 Aug 21
Quarterly holdings report by institutional manager
4:43pm